One of the most successful panels for HCC progression includes a 5-gene panel, based on combined expression level of the genes HN1, RAN, RAMP3, KRT19 and TAF9, that has been shown to be highly predictive of survival time post-resection in HCC patients in multiple cohorts [133]. This evidence concerns the gene TAF9 and hepatocellular carcinoma.